|
|
OTC Healthcare in Portugal to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 188 Pages | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Portugal. This report is a comprehensive resource for market, category and segment level data including va.....
Introduction This databook provides key data and information on the OTC healthcare market in Portugal. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Portugal increased at a compound annual growth rate of 2.6% between 2003 and 2008. The cough and cold preparations category led the OTC healthcare market in Portugal, accounting for a share of 19.2%. Leading players in Portuguese OTC healthcare market include Novartis AG, GlaxoSmithKline Plc and Reckitt Benckiser PLC. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Portugal *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 30 Value analysis (Euro), 2003?08 30 Value analysis (Euro), 2008?13 32 Value analysis (US dollars), 2003?08 34 Value analysis (US dollars), 2008?13 35 Company and brand share analysis 37 Distribution analysis 44 Chapter 4 Leading Company Profiles 46 Novartis AG 46 GlaxoSmithKline Plc 48 Chapter 5 Category Analysis: Analgesics 51 Value analysis (Euro), 2003?08 51 Value analysis (Euro), 2008?13 52 Value analysis (US dollars), 2003?08 54 Value analysis (US dollars), 2008?13 54 Company and brand share analysis 56 Distribution analysis 59 Chapter 6 Category Analysis: Topical OTC Medicines 61 Value analysis (Euro), 2003?08 61 Value analysis (Euro), 2008?13 62 Value analysis (US dollars), 2003?08 64 Value analysis (US dollars), 2008?13 65 Company and brand share analysis 67 Distribution analysis 70 Chapter 7 Category Analysis: Cough and Cold Preparations 72 Value analysis (Euro), 2003?08 72 Value analysis (Euro), 2008?13 73 Value analysis (US dollars), 2003?08 75 Value analysis (US dollars), 2008?13 76 Company and brand share analysis 78 Distribution analysis 81 Chapter 8 Category Analysis: Indigestion Preparations 83 Value analysis (Euro), 2003?08 83 Value analysis (Euro), 2008?13 84 Value analysis (US dollars), 2003?08 86 Value analysis (US dollars), 2008?13 86 Company and brand share analysis 88 Distribution analysis 91 Chapter 9 Category Analysis: Medicated Skin Products 93 Value analysis (Euro), 2003?08 93 Value analysis (Euro), 2008?13 94 Value analysis (US dollars), 2003?08 96 Value analysis (US dollars), 2008?13 97 Company and brand share analysis 99 Distribution analysis 102 Chapter 10 Category Analysis: First Aid Kits 104 Value analysis (Euro), 2003?08 104 Value analysis (Euro), 2008?13 105 Value analysis (US dollars), 2003?08 106 Value analysis (US dollars), 2008?13 106 Company and brand share analysis 107 Distribution analysis 110 Chapter 11 Category Analysis: Other OTC Healthcare Products 112 Value analysis (Euro), 2003?08 112 Value analysis (Euro), 2008?13 113 Value analysis (US dollars), 2003?08 115 Value analysis (US dollars), 2008?13 116 Company and brand share analysis 118 Distribution analysis 121 Chapter 12 Category Analysis: Plasters & Bandages 123 Value analysis (Euro), 2003?08 123 Value analysis (Euro), 2008?13 124 Value analysis (US dollars), 2003?08 126 Value analysis (US dollars), 2008?13 127 Company and brand share analysis 129 Distribution analysis 132 Chapter 13 Category Analysis: Traditional Medicines 134 Value analysis (Euro), 2003?08 134 Value analysis (Euro), 2008?13 135 Value analysis (US dollars), 2003?08 136 Value analysis (US dollars), 2008?13 136 Company and brand share analysis 137 Distribution analysis 140 Chapter 14 Category Analysis: Vitamins and Minerals 142 Value analysis (Euro), 2003?08 142 Value analysis (Euro), 2008?13 143 Value analysis (US dollars), 2003?08 145 Value analysis (US dollars), 2008?13 145 Company and brand share analysis 147 Distribution analysis 149 Chapter 15 Country Comparison 151 Value 151 Market share 155 Chapter 16 PESTLE analysis 156 Summary 156 Political analysis 157 Economic analysis 160 Social analysis 163 Technology analysis 166 Legal analysis 169 Environmental analysis 172 Chapter 17 New Product Development 175 Product launches over time 175 Recent product launches 177 Chapter 18 Macroeconomic Profile 178 Macroeconomic indicators 178 Chapter 19 Research Methodology 183 Methodology overview 183 Secondary research 184 Market modeling 185 Creating an initial data model 185 Revising the initial data model 185 Creating a final estimate 186 Creating demographic value splits 186 Primary research 186 Data finalization 187 Ongoing research 187 Chapter 20 APPENDIX 188 Future readings 188 How to contact experts in your industry 188 Disclaimer 188 LIST OF FIGURES Figure 1: Portugal OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 33 Figure 2: Portugal OTC healthcare category growth comparison, by value, 2003?13 36 Figure 3: Portugal OTC healthcare company share, by value, 2007?08 (%) 41 Figure 4: Portugal OTC healthcare distribution channels, by value, 2007?08 (%) 45 Figure 5: Portugal analgesics value and value forecast, 2003?13 (€m, nominal prices) 53 Figure 6: Portugal analgesics category growth comparison, by value, 2003?13 55 Figure 7: Portugal analgesics company share, by value, 2007?08 (%) 57 Figure 8: Portugal analgesics distribution channels, by value, 2007?08 (%) 60 Figure 9: Portugal topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 63 Figure 10: Portugal topical OTC medicines category growth comparison, by value, 2003?13 66 Figure 11: Portugal topical OTC medicines company share, by value, 2007?08 (%) 68 Figure 12: Portugal topical OTC medicines distribution channels, by value, 2007?08 (%) 71 Figure 13: Portugal cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 74 Figure 14: Portugal cough and cold preparations category growth comparison, by value, 2003?13 77 Figure 15: Portugal cough and cold preparations company share, by value, 2007?08 (%) 79 Figure 16: Portugal cough and cold preparations distribution channels, by value, 2007?08 (%) 82 Figure 17: Portugal indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 85 Figure 18: Portugal indigestion preparations category growth comparison, by value, 2003?13 87 Figure 19: Portugal indigestion preparations company share, by value, 2007?08 (%) 89 Figure 20: Portugal indigestion preparations distribution channels, by value, 2007?08 (%) 92 Figure 21: Portugal medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 95 Figure 22: Portugal medicated skin products category growth comparison, by value, 2003?13 98 Figure 23: Portugal medicated skin products company share, by value, 2007?08 (%) 100 Figure 24: Portugal medicated skin products distribution channels, by value, 2007?08 (%) 103 Figure 25: Portugal first aid kits value and value forecast, 2003?13 (€m, nominal prices) 105 Figure 26: Portugal first aid kits company share, by value, 2007?08 (%) 108 Figure 27: Portugal first aid kits distribution channels, by value, 2007?08 (%) 111 Figure 28: Portugal other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 114 Figure 29: Portugal other OTC healthcare products category growth comparison, by value, 2003?13 117 Figure 30: Portugal other OTC healthcare products company share, by value, 2007?08 (%) 119 Figure 31: Portugal other OTC healthcare products distribution channels, by value, 2007?08 (%) 122 Figure 32: Portugal plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 125 Figure 33: Portugal plasters & bandages category growth comparison, by value, 2003?13 128 Figure 34: Portugal plasters & bandages company share, by value, 2007?08 (%) 130 Figure 35: Portugal plasters & bandages distribution channels, by value, 2007?08 (%) 133 Figure 36: Portugal traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 135 Figure 37: Portugal traditional medicines company share, by value, 2007?08 (%) 138 Figure 38: Portugal traditional medicines distribution channels, by value, 2007?08 (%) 141 Figure 39: Portugal vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 144 Figure 40: Portugal vitamins and minerals category growth comparison, by value, 2003?13 146 Figure 41: Portugal vitamins and minerals distribution channels, by value, 2007?08 (%) 150 Figure 42: Global OTC healthcare market split (value terms, 2008), top five countries 152 Figure 43: Global OTC healthcare market value, 2003–08, top five countries 154 Figure 44: Annual data review process 184 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Portugal OTC healthcare value, 2003?08 (€m, nominal prices) 31 Table 4: Portugal OTC healthcare value forecast, 2008?13 (€m, nominal prices) 32 Table 5: Portugal OTC healthcare value, 2003?08 ($m, nominal prices) 34 Table 6: Portugal OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35 Table 7: Portugal OTC healthcare brand share, by value, 2007?08 (%) 37 Table 8: Portugal OTC healthcare value, by brand 2007?08 (€m, nominal prices) 39 Table 9: Portugal OTC healthcare company share by value, 2007?08 (%) 42 Table 10: Portugal OTC healthcare value, by company, 2007?08 (€m, nominal prices) 43 Table 11: Portugal OTC healthcare distribution channels, by value, 2007?08 (%) 44 Table 12: Portugal OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 44 Table 13: Novartis AG key facts 46 Table 14: GlaxoSmithKline Plc key facts 48 Table 15: Portugal analgesics value, 2003?08 (€m, nominal prices) 51 Table 16: Portugal analgesics value forecast, 2008?13 (€m, nominal prices) 52 Table 17: Portugal analgesics value, 2003?08 ($m, nominal prices) 54 Table 18: Portugal analgesics value forecast, 2008?13 ($m, nominal prices) 54 Table 19: Portugal analgesics brand share, by value, 2007?08 (%) 56 Table 20: Portugal analgesics value, by brand 2007?08 (€m, nominal prices) 56 Table 21: Portugal analgesics company share by value, 2007?08 (%) 58 Table 22: Portugal analgesics value, by company, 2007?08 (€m, nominal prices) 58 Table 23: Portugal analgesics distribution channels, by value, 2007?08 (%) 59 Table 24: Portugal analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 59 Table 25: Portugal topical OTC medicines value, 2003?08 (€m, nominal prices) 61 Table 26: Portugal topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 62 Table 27: Portugal topical OTC medicines value, 2003?08 ($m, nominal prices) 64 Table 28: Portugal topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 65 Table 29: Portugal topical OTC medicines brand share, by value, 2007?08 (%) 67 Table 30: Portugal topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 67 Table 31: Portugal topical OTC medicines company share by value, 2007?08 (%) 69 Table 32: Portugal topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 69 Table 33: Portugal topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Table 34: Portugal topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 70 Table 35: Portugal cough and cold preparations value, 2003?08 (€m, nominal prices) 72 Table 36: Portugal cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 73 Table 37: Portugal cough and cold preparations value, 2003?08 ($m, nominal prices) 75 Table 38: Portugal cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 76 Table 39: Portugal cough and cold preparations brand share, by value, 2007?08 (%) 78 Table 40: Portugal cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 78 Table 41: Portugal cough and cold preparations company share by value, 2007?08 (%) 80 Table 42: Portugal cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 80 Table 43: Portugal cough and cold preparations distribution channels, by value, 2007?08 (%) 81 Table 44: Portugal cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 81 Table 45: Portugal indigestion preparations value, 2003?08 (€m, nominal prices) 83 Table 46: Portugal indigestion preparations value forecast, 2008?13 (€m, nominal prices) 84 Table 47: Portugal indigestion preparations value, 2003?08 ($m, nominal prices) 86 Table 48: Portugal indigestion preparations value forecast, 2008?13 ($m, nominal prices) 86 Table 49: Portugal indigestion preparations brand share, by value, 2007?08 (%) 88 Table 50: Portugal indigestion preparations value, by brand 2007?08 (€m, nominal prices) 88 Table 51: Portugal indigestion preparations company share by value, 2007?08 (%) 90 Table 52: Portugal indigestion preparations value, by company, 2007?08 (€m, nominal prices) 90 Table 53: Portugal indigestion preparations distribution channels, by value, 2007?08 (%) 91 Table 54: Portugal indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 91 Table 55: Portugal medicated skin products value, 2003?08 (€m, nominal prices) 93 Table 56: Portugal medicated skin products value forecast, 2008?13 (€m, nominal prices) 94 Table 57: Portugal medicated skin products value, 2003?08 ($m, nominal prices) 96 Table 58: Portugal medicated skin products value forecast, 2008?13 ($m, nominal prices) 97 Table 59: Portugal medicated skin products brand share, by value, 2007?08 (%) 99 Table 60: Portugal medicated skin products value, by brand 2007?08 (€m, nominal prices) 99 Table 61: Portugal medicated skin products company share by value, 2007?08 (%) 101 Table 62: Portugal medicated skin products value, by company, 2007?08 (€m, nominal prices) 101 Table 63: Portugal medicated skin products distribution channels, by value, 2007?08 (%) 102 Table 64: Portugal medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 102 Table 65: Portugal first aid kits value, 2003?08 (€m, nominal prices) 104 Table 66: Portugal first aid kits value forecast, 2008?13 (€m, nominal prices) 105 Table 67: Portugal first aid kits value, 2003?08 ($m, nominal prices) 106 Table 68: Portugal first aid kits value forecast, 2008?13 ($m, nominal prices) 106 Table 69: Portugal first aid kits brand share, by value, 2007?08 (%) 107 Table 70: Portugal first aid kits value, by brand 2007?08 (€m, nominal prices) 107 Table 71: Portugal first aid kits company share by value, 2007?08 (%) 109 Table 72: Portugal first aid kits value, by company, 2007?08 (€m, nominal prices) 109 Table 73: Portugal first aid kits distribution channels, by value, 2007?08 (%) 110 Table 74: Portugal first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 110 Table 75: Portugal other OTC healthcare products value, 2003?08 (€m, nominal prices) 112 Table 76: Portugal other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 113 Table 77: Portugal other OTC healthcare products value, 2003?08 ($m, nominal prices) 115 Table 78: Portugal other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 116 Table 79: Portugal other OTC healthcare products brand share, by value, 2007?08 (%) 118 Table 80: Portugal other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 118 Table 81: Portugal other OTC healthcare products company share by value, 2007?08 (%) 120 Table 82: Portugal other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 120 Table 83: Portugal other OTC healthcare products distribution channels, by value, 2007?08 (%) 121 Table 84: Portugal other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 121 Table 85: Portugal plasters & bandages value, 2003?08 (€m, nominal prices) 123 Table 86: Portugal plasters & bandages value forecast, 2008?13 (€m, nominal prices) 124 Table 87: Portugal plasters & bandages value, 2003?08 ($m, nominal prices) 126 Table 88: Portugal plasters & bandages value forecast, 2008?13 ($m, nominal prices) 127 Table 89: Portugal plasters & bandages brand share, by value, 2007?08 (%) 129 Table 90: Portugal plasters & bandages value, by brand 2007?08 (€m, nominal prices) 129 Table 91: Portugal plasters & bandages company share by value, 2007?08 (%) 131 Table 92: Portugal plasters & bandages value, by company, 2007?08 (€m, nominal prices) 131 Table 93: Portugal plasters & bandages distribution channels, by value, 2007?08 (%) 132 Table 94: Portugal plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 132 Table 95: Portugal traditional medicines value, 2003?08 (€m, nominal prices) 134 Table 96: Portugal traditional medicines value forecast, 2008?13 (€m, nominal prices) 135 Table 97: Portugal traditional medicines value, 2003?08 ($m, nominal prices) 136 Table 98: Portugal traditional medicines value forecast, 2008?13 ($m, nominal prices) 136 Table 99: Portugal traditional medicines brand share, by value, 2007?08 (%) 137 Table 100: Portugal traditional medicines value, by brand 2007?08 (€m, nominal prices) 137 Table 101: Portugal traditional medicines company share by value, 2007?08 (%) 139 Table 102: Portugal traditional medicines value, by company, 2007?08 (€m, nominal prices) 139 Table 103: Portugal traditional medicines distribution channels, by value, 2007?08 (%) 140 Table 104: Portugal traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 140 Table 105: Portugal vitamins and minerals value, 2003?08 (€m, nominal prices) 142 Table 106: Portugal vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 143 Table 107: Portugal vitamins and minerals value, 2003?08 ($m, nominal prices) 145 Table 108: Portugal vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 145 Table 109: Portugal vitamins and minerals brand share, by value, 2007?08 (%) 147 Table 110: Portugal vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 147 Table 111: Portugal vitamins and minerals company share by value, 2007?08 (%) 148 Table 112: Portugal vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 148 Table 113: Portugal vitamins and minerals distribution channels, by value, 2007?08 (%) 149 Table 114: Portugal vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 149 Table 115: Global OTC healthcare market value, 2008 151 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 154 Table 117: Leading players, top five countries 155 Table 118: Analysis of Portuguese political landscape 157 Table 119: Analysis of the Portuguese economy 160 Table 120: Analysis of the Portuguese social system 163 Table 121: Analysis of Portuguese technology landscape 166 Table 122: Patents granted by the US Patent and Trademark Office to Portugal compared with major developed countries, 2003–06 168 Table 123: Analysis of Portuguese legal landscape 169 Table 124: Analysis of Portuguese environmental landscape 172 Table 125: Portugal OTC healthcare new product launches reports, by company 2008 175 Table 126: Portugal OTC healthcare new product launches SKUs, by company 2008 175 Table 127: Portugal OTC healthcare new product launches (reports), by flavor and fragrances 2008 176 Table 128: Portugal OTC healthcare new product launches (reports), by ingredients 2008 176 Table 129: Portugal OTC healthcare new product launches (reports), by package tags or claims 2008 177 Table 130: Portugal OTC healthcare new product launches, 2008 177 Table 131: Portugal population, by age group, 2003?08 (millions) 178 Table 132: Portugal population forecast, by age group, 2008?13 (millions) 179 Table 133: Portugal population, by gender, 2003?08 (millions) 179 Table 134: Portugal population forecast, by gender, 2008?13 (millions) 180 Table 135: Portugal nominal GDP, 2003?08 (€bn, nominal prices) 180 Table 136: Portugal nominal GDP forecast, 2008?13 (€bn, nominal prices) 180 Table 137: Portugal real GDP, 2003?08 (€bn, 2000 prices) 181 Table 138: Portugal real GDP forecast, 2008?13 (€bn, 2000 prices) 181 Table 139: Portugal real GDP, 2003?08 ($bn, 2000 prices) 181 Table 140: Portugal real GDP forecast, 2008?13 ($bn, 2000 prices) 182 Table 141: Portugal consumer price index, 2003?08 (2000=100) 182 Table 142: Portugal consumer price index, 2008?13 (2000=100) 182 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


